Caribou Biosciences (CRBU) Cash & Equivalents (2020 - 2026)
Caribou Biosciences (CRBU) recorded Cash & Equivalents of $26.19 million in Q2 2026, up 3.9% from $25.2 million a year earlier and up 117.3% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Cash & Equivalents of $12.36 million, down 24.1% from FY2024.
- Annual Cash & Equivalents has declined for four straight years, with a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $16.29 million in FY2024 (-68.2%), $51.16 million in FY2023 (-12.3%), $58.34 million in FY2022 (-75.7%) and $240.42 million in FY2021.
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in 1 of the last eight quarters, with an average decline of 44.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 26.8% in Q3 2023, against a decline of 81.1% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.06 million (Q1 2026), $12.36 million (Q4 2025) and $11.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Caribou Biosciences | 129.31 Mn | -387.22 Mn | - | 26.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.19 Mn |
| Mar 31, 2026 | 12.06 Mn |
| Dec 31, 2025 | 12.36 Mn |
| Sep 30, 2025 | 11.14 Mn |
| Jun 30, 2025 | 25.20 Mn |
| Mar 31, 2025 | 29.42 Mn |
| Dec 31, 2024 | 16.29 Mn |
| Sep 30, 2024 | 31.97 Mn |
| Jun 30, 2024 | 37.87 Mn |
| Mar 31, 2024 | 49.40 Mn |
| Dec 31, 2023 | 51.16 Mn |
| Sep 30, 2023 | 104.06 Mn |
| Jun 30, 2023 | 66.19 Mn |
| Mar 31, 2023 | 52.74 Mn |
| Dec 31, 2022 | 58.34 Mn |
| Sep 30, 2022 | 82.09 Mn |
| Jun 30, 2022 | 112.15 Mn |
| Mar 31, 2022 | 147.63 Mn |
| Dec 31, 2021 | 240.42 Mn |
| Sep 30, 2021 | 435.31 Mn |
API Access
Caribou Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();